Elaborate biologic approval process delays care of patients with moderate-to-severe asthma.
Sehanobish E, Ye K, Imam K, Sariahmed K, Kurian J, Patel J, Belletti D, Chung Y, Jariwala S, White A, Jerschow E.
Sehanobish E, et al. Among authors: jerschow e.
J Allergy Clin Immunol Glob. 2023 Jan 11;2(2):100076. doi: 10.1016/j.jacig.2022.10.007. eCollection 2023 May.
J Allergy Clin Immunol Glob. 2023.
PMID: 37780792
Free PMC article.